StockClub

HQL

HQLTekla Life Sciences Investors$ --
Tekla Life Sciences Investors

Tekla Life Sciences Investors

HQL

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q2
Revenue
48M USD
YoY +164.1%
Operating Income
65M USD
YoY +238.3%
Net Income
65M USD
YoY +238.3%
EPS
2.15$
YoY +231.1%

Revenue

$48.1M
FY2022 Q4$31.9M
$31.9M
Q4
FY2023 Q2$1.9M
$1.9M
Q2
FY2023 Q4$31.5M
$31.5M
Q4
FY2024 Q2$2.1M
$2.1M
Q2
FY2024 Q4$4M
$4M
Q4
FY2025 Q2$18.2M
$18.2M
Q2
FY2025 Q4$29.8M
$29.8M
Q4
FY2026 Q2$48.1M
$48.1M
Q2
Actual
+$29.9M (+164.1%)

Net Income

$65.3M
FY2022 Q4$-104.6M
$-104.6M
Q4
FY2023 Q2$33.8M
$33.8M
Q2
FY2023 Q4$22.4M
$22.4M
Q4
FY2024 Q2$50.3M
$50.3M
Q2
FY2024 Q4$85.3M
$85.3M
Q4
FY2025 Q2$-47.2M
$-47.2M
Q2
FY2025 Q4$85.6M
$85.6M
Q4
FY2026 Q2$65.3M
$65.3M
Q2
Actual
+$112.6M (+238.3%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$39.1M
FY2020
$39.1M
FY2021
Actual:$45M
FY2021
$45M
FY2022
Actual:$31.9M
FY2022
$31.9M
FY2023
Actual:$39.4M
FY2023
$39.4M
FY2024
Actual:$86.7M
FY2024
$86.7M
FY2025
Actual:$86.4M
FY2025
$86.4M

Analyst Estimates

No forecast data